The blasts react with antibodies to myeloperoxidase and antibodies to CD13, CD33, and CD34. Human leukocyte antigen (HLA)-DR is ... but immunophenotyping demonstrates myeloid antigens. In acute myeloblastic leukemia (M0), the blasts are agranular and ...
Unlike myeloid dendritic cells, myeloid antigens like CD11b, CD11c, CD13, CD14 and CD33 are not present on pDC surfaces. ... In humans, pDCs exhibit plasma cell morphology and express CD4, HLA-DR, CD123, blood-derived dendritic cell antigen-2 (BDCA-2 ... Villadangos, José A.; Young, Louise (September 2008). "Antigen-Presentation Properties of Plasmacytoid Dendritic Cells". ... which allows the cell to optimize its antigen-presenting abilities. MHC class I on pDC surfaces are able to activate CD8+ T ...
... close correlation with expression of myeloid-associated antigen CD13". Leukemia. 6 (7): 662-8. PMID 1378163. Lynch M, Baker E, ...
Kao YR, Shih JY, Wen WC, Ko YP, Chen BM, Chan YL, Chu YW, Yang PC, Wu CW, Roffler SR (Jul 2003). "Tumor-associated antigen L6 ... Chang YW, Chen SC, Cheng EC, Ko YP, Lin YC, Kao YR, Tsay YG, Yang PC, Wu CW, Roffler SR (Aug 2005). "CD13 (aminopeptidase N) ... This encoded protein is a cell surface antigen and is highly expressed in different carcinomas. GRCh38: Ensembl release 89: ... "The carboxy-terminal cysteine of the tetraspanin L6 antigen is required for its interaction with SITAC, a novel PDZ protein". ...
The MEROPS online database for peptidases and their inhibitors: M01.001 CD13+Antigens at the U.S. National Library of Medicine ... Sequence comparisons with known enzymes of this class showed that CD13 and aminopeptidase N are identical. The latter enzyme ... Look AT, Ashmun RA, Shapiro LH, Peiper SC (April 1989). "Human myeloid plasma membrane glycoprotein CD13 (gp150) is identical ... Söderberg C, Giugni TD, Zaia JA, Larsson S, Wahlberg JM, Möller E (November 1993). "CD13 (human aminopeptidase N) mediates ...
... antigens, cd13 MeSH D08.811.277.656.350.555.200 - carboxypeptidase b MeSH D08.811.277.656.350.555.250 - carboxypeptidase h MeSH ... antigens, cd13 MeSH D08.811.277.656.675.555.200 - carboxypeptidase b MeSH D08.811.277.656.675.555.250 - carboxypeptidase h MeSH ... antigens, cd13 MeSH D08.811.277.656.350.100.235 - cystinyl aminopeptidase MeSH D08.811.277.656.350.100.373 - glutamyl ... antigens, cd38 MeSH D08.811.277.450.770 - oligo-1,6-glucosidase MeSH D08.811.277.450.770.800 - sucrase-isomaltase complex MeSH ...
... antigens, cd7 MeSH D23.050.301.264.894.108 - antigens, cd8 MeSH D23.050.301.264.894.113 - antigens, cd13 MeSH D23.050.301.264. ... antigens, cd13 MeSH D23.050.301.264.035.114 - antigens, cd14 MeSH D23.050.301.264.035.115 - antigens, cd15 MeSH D23.050.301.264 ... antigens, cd13 MeSH D23.101.100.110.114 - antigens, cd14 MeSH D23.101.100.110.115 - antigens, cd15 MeSH D23.101.100.110.118 - ... antigens, cd7 MeSH D23.101.100.894.108 - antigens, cd8 MeSH D23.101.100.894.113 - antigens, cd13 MeSH D23.101.100.894.118 - ...
Rehli M, Krause SW, Kreutz M, Andreesen R (June 1995). "Carboxypeptidase M is identical to the MAX.1 antigen and its expression ... "Distribution of carboxypeptidase M on lymphoid and myeloid cells parallels the other zinc-dependent proteases CD10 and CD13". ...
White Cell Differentiation Antigens. Oxford University Press. Knapp, W; et al. (1989). Leucocyte Typing IV. Oxford University ... Antibodies CD71/Transferrin receptor-1 CD13 marker for kidney disorder CD33 marker for AML treatment CD4+/CD8+ ratio Immune ... "CD Antigens" (PDF). abcam. 2009. Retrieved 2014-11-22. Passlick B, Flieger D, Ziegler-Heitbrock HW (1989). "Identification and ... The CD designations were used to describe the recognized molecules, but had to be clarified by attaching the term antigen or ...
... +Antigen at the U.S. National Library of Medicine Medical Subject Headings (MeSH) Human CD164 genome location and CD164 ... 2005). "Identification of CD13, CD107a, and CD164 as novel basophil-activation markers and dissection of two response patterns ...
... which is a glycoprotein that serves as a ligand for macrophage-1 antigen (Mac-1) and lymphocyte function-associated antigen 1 ( ... September 2018). "A functional glycoproteomics approach identifies CD13 as a novel E-selectin ligand in breast cancer". ... which is a glycoprotein that serves as a ligand for macrophage-1 antigen (Mac-1) and lymphocyte function-associated antigen 1 ( ... July 2008). "Antigen-specific T-cell induction by vaccination with a recombinant Sendai virus vector even in the presence of ...
This TNF-based AcTakine resulted in a 100-fold increase in targeting efficiency, and when the AcTakine was targeted to CD13 ... The cytokine is activated upon binding to its tumor-specific antigen, allowing for local delivery. The cytokine tumor necrosis ... Immunocytokines are delivered systemically but can specifically target the tumor through overexpressed or unique tumor antigens ... is an antibody-cytokine conjugate that links the cytokine IL-2 with an antibody targeting the carcinoembryonic antigen (CEA). ...
Azuma Y, Ito M, Taniguchi A, Matsumoto K (June 2004). "Expression of cell surface Lewis X and Y antigens and FUT4 mRNA is ... Cruse JM, Lewis RE, Sanders CM, Webb RN, Beason KL, Lam J, Koehler J (October 2007). "Diminished CD10, CD13, and CD15 ... Azuma Y, Kurusu Y, Sato H, Higai K, Matsumoto K (April 2007). "Increased expression of Lewis X and Y antigens on the cell ... Higai K, Ichikawa A, Matsumoto K (September 2006). "Binding of sialyl Lewis X antigen to lectin-like receptors on NK cells ...
doi:10.1158/2159-8290.CD-13-0424. PMC 4154497. PMID 24771846. Robinson G, Parker M, Kranenburg TA, Lu C, Chen X, Ding L, et al ... "An N-acetylated natural ligand of human histocompatibility leukocyte antigen (HLA)-B39. Classical major histocompatibility ...
Examples of tumoral markers used to follow up cancer treatment are the Carcinoembryonic Antigen (CEA) for colorectal cancer and ... doi:10.1158/2159-8290.CD-13-1014. PMC 4433544. PMID 24801577. (All articles with dead external links, Articles with dead ... More recently, biomarker is becoming a synonym for molecular biomarker, such as elevated prostate specific antigen as a ... antibodies to citrullinated antigens". Dtsch Ärztebl Int. 106 (10): 159-63. doi:10.3238/arztebl.2009.0159. PMC 2695367. PMID ...
Rescuing imperfect antigens for immune-oncology. Nat Biotech. Epub ahead of print. Aug 2019. "Peter Edward Fecci". "Leadership ... doi:10.1158/2159-8290.CD-13-0310. PMC 3864135. PMID 24078774. Chongsathidkiet, P.; Jackson, C.; Koyama, S.; Loebel, F.; Cui, X ...
Mast cell differentiation antigens: expression in normal and malignant cells and use for diagnostic purposes". Eur. J. Clin. ... The leukemic cells usually are strongly positive for CD13, CD33, CD68, and CD117. Characteristically, basophil (e.g. CD11b, ...
Recently, Heneberg proposed that basophils may be defined as the cellular population positive for CD13, CD44, CD54, CD63, CD69 ... pollen proteins or helminth antigens). Recent studies in mice suggest that basophils may also regulate the behavior of T cells ... When activated, some additional surface markers are known to be upregulated (CD13, CD107a, CD164), or surface-exposed (CD63, ...
When it is functional, it can cause immune unresponsiveness to self-antigens via both central and peripheral tolerance. In the ... doi:10.1158/2159-8290.CD-13-0609. PMC 3975047. PMID 24346116. Liao G (12 August 2011). "ABT-199 BH-3 Mimetic Enters Phase Ia ... Due to the fact that dendritic cells are the immune system's most important antigen-presenting cells, their activity must be ... Antibodies to Bcl-2 can be used with immunohistochemistry to identify cells containing the antigen. In healthy tissue, these ...
CD13): Influence of N-Linked Glycosylation". Journal of Virology. 75 (20): 9741-52. doi:10.1128/JVI.75.20.9741-9752.2001. PMC ... There are also two different serotypes found with different antigens that produce unique antibodies. FCoV serotype I (also ...
3 (9): 1020-9. doi:10.1158/2159-8290.CD-13-0226. PMID 23779130. Litt JZ (25 January 2013). Litt's Drug Eruptions and Reactions ... including significantly greater relative decreases and increases in levels of prostate-specific antigen (PSA) and testosterone ...